METB-01 METABOLIC REPROGRAMMING DURING RESISTANCE TO ANTI-ANGIOGENIC THERAPY

Por Kuang, Ruby, Mascharak, Smita, Jahangiri, Arman, Imber, Brandon, De Lay, Michael, Castro, Brandyn, Sidrov, Maxim, Miller, Liane, Yagnik, Garima, Aghi, Manish
Publicado no Neuro Oncol (2015)

MTR-01 BEVACIZUMAB-INDUCED MIF DEPLETION: A NOVEL RESISTANCE MECHANISM IN GLIOBLASTOMA

Por Castro, Brandyn, Jahangiri, Arman, Kuang, Ruby, De Lay, Michael, Kohanbash, Gary, Yagnik, Garima, Miller, Liane, Shrivastav, Shruti, Okada, Hideho, Aghi, Manish
Publicado no Neuro Oncol (2015)

DRES-08. A NOVEL XENOGRAFT MODEL REVEALS A GENE CASCADE AND SERUM BIOMARKER DEFINING A MESENCHYMAL TRANSITION DURING THE EVOLUTION OF GLIOBLASTOMA RESISTANCE TO ANTI-ANGIOGENIC THE...

Por Jahangiri, Arman, Chen, William, Nguyen, Alan, Rick, Jonathan, Kuang, Ruby, Sidorov, Maxim, Flanigan, Patrick M, Wagner, Jeffrey R, Carbonell, W Shawn, Yagnik, Garima, Aghi, Manish K
Publicado no Neuro Oncol (2017)

Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure

Por Flanigan, Patrick M, Jahangiri, Arman, Kuang, Ruby, Truong, Albert, Choi, Sarah, Chou, Alvin, Rick, Jonathan W, Chang, Susan M, Molinaro, Annette M, McDermott, Michael W, Berger, Mitchel S, Aghi, Manish K
Publicado no Neurosurgery (2017)

GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance

Por Kuang, Ruby, Jahangiri, Arman, Mascharak, Smita, Nguyen, Alan, Chandra, Ankush, Flanigan, Patrick M., Yagnik, Garima, Wagner, Jeffrey R., De Lay, Michael, Carrera, Diego, Castro, Brandyn A., Hayes, Josie, Sidorov, Maxim, Garcia, Jose Luiz Izquierdo, Eriksson, Pia, Ronen, Sabrina, Phillips, Joanna, Molinaro, Annette, Koliwad, Suneil, Aghi, Manish K.
Publicado no JCI Insight (2017)